Drug Type Antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable Bowel Syndrome | Clinical | Switzerland | 23 Sep 2021 | |
Inflammatory Bowel Diseases | Preclinical | Switzerland | 30 Jan 2022 | |
Inflammatory Bowel Diseases | Preclinical | Switzerland | 30 Jan 2022 |